Select the hypolipidemic drug that enhances
lipoprotein synthesis, fatty acid oxidation and LDLreceptor expression in liver through paroxisome
proliferator-activated receptor α:
A. Lovastatin
B. Atorvastatin
C. Bezafibrate
D. Nicotinic acid
lipoprotein synthesis, fatty acid oxidation and LDLreceptor expression in liver through paroxisome
proliferator-activated receptor α:
A. Lovastatin
B. Atorvastatin
C. Bezafibrate
D. Nicotinic acid